FDA Vaccine Chief to Exit in April
WASHINGTON, D.C. — Dr. Vinay Prasad, the FDA’s top vaccines and biologics regulator, will leave the agency at the end of April, a move announced by FDA Commissioner Marty Makary.…
FDA proposes rare-disease therapy fast track
WASHINGTON, Feb. 23, 2026 — The U.S. Food and Drug Administration proposed a new “plausible mechanism” framework to speed approvals of individualized therapies for rare, life‑threatening genetic diseases, allowing developers…